Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Phenex Pharmaceuticals (FarnesoidX receptor program)

M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Provider of treatment for liver disease. The Unit makes small molecule FXR agonists for the treatment of liver diseases including nonalcoholic steatohepatitis.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Medical Supplies
Other Industries
Other Devices and Supplies
Acquirer
Primary Office
  • Germany

Phenex Pharmaceuticals (FarnesoidX receptor program) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Phenex Pharmaceuticals (FarnesoidX receptor program)‘s full profile, request access.

Request full access to PitchBook

Phenex Pharmaceuticals (FarnesoidX receptor program) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Phenex Pharmaceuticals (FarnesoidX receptor program)‘s full profile, request access.

Request full access to PitchBook